|
C1ORF109 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.10820000030077E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.62610000037967E-07 |
| Normal-vs-Stage2 |
2.797000E-03 |
| Normal-vs-Stage3 |
1.292440E-02 |
| Normal-vs-Stage4 |
9.748200E-01 |
| Stage1-vs-Stage2 |
9.828200E-01 |
| Stage1-vs-Stage3 |
4.858000E-01 |
| Stage1-vs-Stage4 |
5.362200E-02 |
| Stage2-vs-Stage3 |
5.380400E-01 |
| Stage2-vs-Stage4 |
5.630100E-02 |
| Stage3-vs-Stage4 |
1.387630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22750000003591E-06 |
| Normal-vs-AfricanAmerican |
6.39139999999427E-05 |
| Normal-vs-Asian |
7.041000E-01 |
| Caucasian-vs-AfricanAmerican |
6.271800E-01 |
| Caucasian-vs-Asian |
3.846600E-01 |
| AfricanAmerican-vs-Asian |
2.667400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42619999979432E-07 |
| Normal-vs-Female |
6.697600E-03 |
| Male-vs-Female |
1.497150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.060100E-03 |
| Normal-vs-Extreme_Weight |
1.45029999998325E-06 |
| Normal-vs-Obese |
4.012300E-04 |
| Normal-vs-Extreme_Obese |
1.056760E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.364000E-01 |
| Normal_Weight-vs-Obese |
9.428800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.745600E-01 |
| Extreme_Weight-vs-Obese |
5.342400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.408000E-01 |
| Obese-vs-Extreme_Obese |
9.002600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.071000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.123470E-03 |
| Normal-vs-Age(61-80Yrs) |
2.98520000052704E-07 |
| Normal-vs-Age(81-100Yrs) |
9.033500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.091400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.327420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.034100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.255800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.893760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.40899999995425E-06 |
| Normal-VS-Type2 PRCC |
4.8833000000359E-06 |
| Normal-VS-KIRP CIMP |
7.830200E-01 |
| Normal-VS-Unclassified PRCC |
6.102200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.641980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.046200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.327800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.796500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.867800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.377800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50180000002553E-06 |
| Normal-vs-N1 |
6.915200E-01 |
| Normal-vs-N2 |
4.702800E-01 |
| N0-vs-N1 |
1.960180E-02 |
| N0-vs-N2 |
5.267800E-01 |
| N1-vs-N2 |
5.438200E-01 |
|
|
